Addition of 株式会社ゼリアップ as a Consolidated Subsidiary and Establishment of Tillotts Pharma Italy s.r.l.
First written in FY2022-Q1. 1 of 2 entries say "Restated". Latest entry: FY2022-Q3.
1 other company's latest entry also says "Restated".
- FY2022-Q3RestatedAnnual report
「During the first quarter, 株式会社ゼリアップ, which had been a non-consolidated subsidiary through the previous consolidated fiscal year, was included in the scope of consolidation because its materiality had increased. Tillotts Pharma Italy s.r.l. was also included in the scope of consolidation because it was newly established.」
The addition of 株式会社ゼリアップ to the scope of consolidation and the establishment and consolidation of Tillotts Pharma Italy s.r.l. continue to be disclosed. - FY2022-Q1First statedAnnual report
「During the current first quarter, 株式会社ゼリアップ, which had been a non-consolidated subsidiary through the previous consolidated fiscal year, was included in the scope of consolidation because its materiality had increased. Tillotts Pharma Italy s.r.l. was also included in the scope of consolidation because it was newly established.」
株式会社ゼリアップ, whose materiality had increased, was added to the scope of consolidation, and the newly established Tillotts Pharma Italy s.r.l. was also incorporated as a consolidated subsidiary.